 |
A number of new drugs are under development for the treatment of lymphoma, some specifically targeting ALCL.
A clinical trial is a research study of a new therapy that has already been successfully tested in laboratory animals and is ready to be tried on humans. It is designed to answer specific questions about a new drug or treatment.
Clinical trials are typically divided into the following phases:
| Phase I |
In phase I clinical trials, researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. |
| Phase II |
In phase II clinical trials, the study drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety. |
| Phase III |
In phase III studies, the study drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments and collect information that will allow the drug or treatment to be used safely. |
| Phase IV |
Phase IV studies are often done after the drug or treatment has been marketed. These studies continue testing the study drug or treatment to collect information about their effect in various populations and any side effects associated with long-term use. |
|
